| Period Ending | 31-Dec-2012 | 31-Dec-2011 | 31-Dec-2010 |
|---|
|
Total Revenue
|
164,842
|
138,064
|
95,623
| | Cost of Revenue | 32,486 | 24,974 | 20,042 | | |
Gross Profit
|
132,356
|
113,090
|
75,581
| |
|
Operating Expenses |
|
Research Development | 36,178 | 27,744 | 19,616 |
|
Selling General and Administrative | 70,774 | 57,910 | 45,921 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
25,404
|
27,436
|
10,044
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 455 | 278 | (122) |
|
Earnings Before Interest And Taxes | 25,859 | 27,714 | 9,922 |
|
Interest Expense | 6,925 | 3,592 | 757 |
|
Income Before Tax | 18,934 | 24,122 | 9,165 |
|
Income Tax Expense | 6,858 | (8,175) | 1,169 |
|
Minority Interest |
-
|
-
| (4) |
|
|
|
Net Income From Continuing Ops | 12,076 | 32,297 | 7,992 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
12,076
|
32,297
|
7,992
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
12,076
|
32,297
|
7,992
|
|